TELL US ABOUT YOURSELF.
After graduating from medical school in Beijing, China, I came to the University of Florida (UF) to obtain a PhD degree in molecular pathology & immunology. I then completed a residency in anatomic pathology and clinical pathology as well as a fellowship in cytopathology at UF. In 2005, after achieving American Board of Pathology certification, I accepted the assistant professor position at Moffitt Cancer Center (MCC or Moffitt) and I was promoted to professor/senior member in 2015. MCC is one of the premier cancer centers in the US and the only NCI designated cancer center in Florida (https://moffitt.org/providers/marilyn-bui/). My daily goal is to provide the best possible patient care as a pathologist with expertise in bone and soft tissue pathology, cytopathology, breast cancer biomarker testing and digital pathology. I am also involved in research, education, advocacy and other service activities which allow me to have a positive impact on patient care in a broader sense, not just one patient at a time.
HOW LONG HAVE YOU BEEN WORKING WITH DIGITAL PATHOLOGY?
During my time at the University of Florida from 1995-2005, I worked with Dr. Shala Masood, a breast pathology expert, using quantitative image analysis for breast cancer biomarker testing in various research projects. When I started at Moffitt Cancer Center in 2005, I had the privilege and honor to serve as the Scientific Director of the Analytic Microscopy Core (AMC) Laboratory where digital pathology (whole slide imaging, image analysis, and more) is a key service provided to support the cancer center researchers’ investigational work. In my clinical practice, I have been using an FDA-approved commercially available platform of breast cancer biomarker quantitative image analysis (QIA). I also use digital pathology for tumor boards, teaching, consultation, research and publication.
CLICK HERE to continue reading
|MEMBER SPOTLIGHT ARCHIVE|
For more information on membership levels, please click here.